$COHR
观点汇总
由 AI 根据下方全部推文生成，仅为阅读辅助，以原推为准
Serenity 认为 COHR 是 Google TPU v7 光网络供应链中的次要参与者，虽受益于超大规模云厂商 ASIC 建设，但相比拥有 OCS 垄断优势的 Lumentum ($LITE)，其竞争地位较弱。他看重 COHR 在光子学领域的双寡头地位及其新建的 6 英寸磷化铟 (InP) 晶圆厂，指出其产能已满载且受限于上游 InP 原料瓶颈。随着 AI 建设向光子学转型，InP 衬底成为关键瓶颈，COHR 作为西方供应链中近乎垂直整合的希望，面临巨大的供应挑战与机遇。尽管 COHR 股价表现强劲，Serenity 并未将其列为“强烈买入”，而是给予“买入”评级，认为其受限于原料垄断且非最高确信度标的，但仍是 AI 资本支出浪潮中值得配置的光子学受益者。
相关推文
共 253 条 · 按时间倒序 · 滚到底自动加载更多
-
LITE财报超预期，指引强劲，看好CPO渗透及同行受益。
$LITE 财报出炉，表现非常强劲： 营收：10.1亿美元，环比+24.5%，同比+109.3% vs. 预期约9.846亿美元 调整后每股收益(Adj. EPS)：3.23美元 vs. 预期约2.95美元 毛利率(非GAAP)：50.4% / 营业利润率(非GAAP) 36.6% FY2027 Q1指引可能更重要： 营收：12.25亿–12.75亿美元 vs. 预期约11.6亿美元 调整后每股收益：4.05–4.35美元 vs. 预期约3.63美元 营业利润率(非GAAP) 39.5% - 40.5% 关于备注： 看到：“对超高功率共封装光学(CPO)激光器的需求增加，ELS模块获得初始订单” - 对其他CPO玩家如 $SIVEF、$COHR 等有很好的传导效应(read through)。(可能不包括 $AAOI，因为它们错过了第一代部署) - “NPO参与的广度是光学开始渗透机架内连接性的初步迹象，显著提升了我们的光学总可寻址市场(TAM)” - 营收预测“比目标模型提前一个多季度达成。” 正如预期的极其强劲的财报，营收从： 8.08亿 -> 10.1亿 -> 12.5亿，同时营业利润率持续增加... 这只是我的初步印象。 最重要的是即将召开的财报电话会议。
英文原文
$LITE earnings are out, very strong earnings: Revenue: $1.01B, +24.5% Q/Q, +109.3% Y/Y growth vs. ~$984.6M Adj. EPS: $3.23 vs. ~$2.95 Gross Margin (non-gaap): 50.4% / Operating margin (non-gaap) 36.6% Q1 FY2027 guidance is probably more important: Revenue: $1.225–1.275B vs. ~$1.16B Adj. EPS: $4.05–4.35 vs. ~$3.63 Operating margin (non-gaap) of 39.5% - 40.5% In terms of notes: Sees: "Increasing demand for ultra-high-power CPO lasers, an initial order for ELS modules" - Great read through on other CPO players like $SIVEF, $COHR, and others. (maybe not AAOI since they're missing out on first-gen deployments) - "Breath of NPO engagements are the first signs that optics are starting to penetrate in-rack connectivity, significantly upping our optical TAM" - Revenue projections "reaching our target model more than a quarter ahead of schedule." Extremely strong earnings as expected, you have revenue going from: $808M -> $1.01B -> $1.25B while operating margin keeps increasing... Just my first impressions. Most important thing is the earnings call coming up soon.
-
市场在瓶颈间轮动，基本面未变仅估值波动，建议理性看待。
是的，我依然看好存储芯片，如 $MU / 三星。正如我之前所说，市场倾向于在瓶颈之间轮动。本周看来，光子学领域从 $AXTI 到 $LITE 再次成为焦点。关键在于……主要变化的是股价，随后辅以一些叙事和零星更新。对于光子学：> 在7月的下跌中，我们已经知道 $COHR / $LITE 的激光器已完全售罄，未来两年无货。> 我们从上季度财报电话会中已知 $AAOI 的需求失衡。7月崩盘期间，除了清算后的挂牌价外，基本面没有任何恶化。然而，当 $AAOI 跌至 $75 或 $AXTI 跌至 $35 时，许多人称其为“骗局”……但当它们涨回 $140 或 $80 时，人们又看多了，尽管光模块/磷化铟(InP)衬底瓶颈未变，甚至可能更糟（例如美国拟禁止中国新光模块，需求预测上调）。对于存储：我目睹大量散户投降，但这些人一个月前在 $MU 签署16份SCA并给出卓越指引时曾极度看多。或曾庆祝三星拥有全球最高营业利润。这里有一些更新，例如 Rubin Ultra 的存储优化（Nvidia每代都在追求），价格不再极端高于预期。但在当前价格下，营业利润相对于市值简直荒谬，尤其是存储成为结构性需求。明年的需求失衡应该更严重。人们倾向于在板块下跌时投降并跟随叙事（例如伊朗战争期间的氦气/LNG），即使瓶颈或基本面未变（例如 $SPCX Elon 财报电话会重申存储紧张）。我不能告诉别人该做什么：但 $140 的 $AAOI 和 $75 的 $AAOI 是同一家公司。市值 $1.5T 的三星和 $980B 的三星是同一家公司。只是估值和叙事（通常是噪音）在变，市场在板块间轮动。
英文原文
Yes, I'm still bullish on memory like $MU / Samsung. As I said earlier, markets tend to rotate from bottleneck to bottleneck. This week it looks $AXTI to $LITE in the photonics sector is the focus again. The thing is... the primary thing that changed are the stock prices, followed by some narratives + updates sprinkled in here and there. For photonics: > We already knew $COHR / $LITE lasers were completely sold out for the next 2 years during July's drop. > We knew about demand imbalance from $AAOI from last quarter's earnings calls. Nothing deteriorated fundamentally during July's crash, other than listed price after liquidations. Yet tons of people called $AAOI a "scam" when it dropped to $75, or $AXTI a "scam" on its drop to $35... But are bullish again at $140 or $80, when the transciver/InP substrate bottleneck hasn't changed at all, but maybe even got worse... (eg. draft for US ban on new china optical transceivers, scale up demand projections) For Memory: I'm witnessing a lot of retail capitulation, but the same people I'm seeing were mega bullish after $MU signed 16 SCAs and gave exceptional projections a month ago. Or were celebrating Samsung having the highest operating profit in the world. There's updates here and there eg. Rubin Ultra with memory optimizations (which Nvidia strives for every generation), with prices no longer being hiked way above expectations to the extreme. But the operating income relative to MC is just absurd around current prices, especially memory becomes structural. And the demand imbalance should be even worse next year. People tend to capitulate and follow narratives when a sector drops (eg. Helium/LNG back in Iran war), even if the bottleneck or fundamental situation hasn't really changed much (eg. $SPCX Elon earnings call reiterating memory tightness). I can't tell others what to to do: But $AAOI at $140 and $AAOI at $75 are the same company. Samsung at a $1.5T MC and Samsung at a $980B MC are the same company. Just valuations and narratives (often noise) change, and markets rotate from sector to sector.
-
AAOI缺席CPO部署揭示产能瓶颈，暗示其他CPO玩家价值被低估。
@00m00oo 我对 $AAOI 极度看好，它是我的核心持仓之一？ 但当 AOI 表示因产能不足而不参与第一代共封装光学(CPO)部署时，背后有无数问题需要拆解。 1. 独立连续波分布反馈激光器(CW DFB)产能，比市场预期的更少。 2. 合格的 CPO 激光器玩家，比市场预期的更少。 3. 我记得 Rosenblatt 曾认为 $AAOI 会是 $AMD 的第一个 CPO 客户，但情况可能已变... 而且由于 $LITE 和 $COHR 站在 $NVDA 阵营且未来两年订单已售罄... 其他一些 CPO 玩家可能比人们认为的更有价值。
英文原文
@00m00oo I'm extremely bullish on $AAOI, it's one of my top holdings? But there's an unholy amount of things to unpack when AOI said they're not participating in first-gen CPO deployments because there's not enough capacity. 1. Independent CW DFB capacity, even less than markets thought. 2. Qualified CPO laser players, even less than markets thought. 3. I remember Rosenblatt thought $AAOI would be $AMD's first CPO customer, but might not be the case anymore... And since $LITE and $COHR are in camp $NVDA and sold out for next 2 years... Some other CPO players might be more valuable than others think.
-
AAOI财报揭示CPO激光器产能瓶颈，利好少数西方厂商，中国技术落后数年。
哇，$AAOI 的财报中对于 $SIVE 及其他激光器玩家来说，利好一个接一个。 1. $AAOI 并未实质性参与第一代共封装光学(CPO)部署。 “我们根本无法生产足够的[CPO激光器]来参与他们当前的一代[CPO]部署，因为产能根本不够。我们必须优先保障自有光模块的激光器供应。” 因此，第一代CPO激光器的部署范围可能会进一步缩小，仅限于$SIVE、$LITE、$AVGO和$COHR等西方厂商。 如果$AAOI不得不拒绝更多客户，独立的CPO连续波(CW)激光器产能将变得更有价值。 还要记得Trendforce曾提到$AMD签署了CW长期协议(LTA)？$COHR/$LITE已与$NVDA签署了产能协议…… 我原以为是$AAOI，但他们可能出局了。$MTSI在早期CPO参与中也不显眼（除了NPO外财报未提及，且从Ayar网站移除）。 所以我在想$AMD在Helios项目中会与谁合作（例如Sivers+Ayar现在更可能是候选者）？ 顺便说一句，这对$AAOI并非看空，因为他们光模块业务需求旺盛。只是对少数有产能的合格CPO激光器厂商更加看多。 2. 磷化铟(InP)激光器/光模块的需求失衡与瓶颈。 AOI CEO的话某种程度上证实了这一点：“客户需求比扩建后的产能高出20%-40%。” “我们几乎每周都从几家大客户那里收到这种需求。激光器目前是光模块业务最大的瓶颈。” 3. 中国在CPO波分复用(DWDM)规格激光器方面落后数年。 我之前在渠道调研CPO竞争时曾覆盖过这一点。 但$AAOI确认中国“至少落后两三年甚至更久”才能拥有CPO激光器，这极大地印证了西方激光器在CPO激光器卡脖子环节上的防御性地位。 总结： - CW激光器和光模块需求严重失衡。 - $AAOI因产能限制未进入第一代CPO（对$AAOI不算看空，因其光模块需求旺盛，但对$SIVE等少数有产能的独立厂商更是利好）。 - 中国在CPO激光器方面落后数年。
英文原文
Wow, there's gem after gem in $AAOI earnings for $SIVE + other laser player readthrough. 1. AAOI not meaningfully participating in CPO first-gen deployments. "We just can’t make enough of them [CPO lasers] to be involved in their current first-generation [CPO] deployments because there’s just not enough capacity. We have to prioritize our ability to make lasers for our own transceivers first" So first-gen CPO laser deployments, might even be narrowed down further for Western players like $SIVE, $LITE, $AVGO, and $COHR. And independent CPO CW laser capacity became more valuable if $AAOI had to turn away more customers... Also remember Trendforce was talking about $AMD singing CW LTAs? $COHR / $LITE have capacity signed with $NVDA ... I thought it would be $AAOI, but they might be out of the equation. $MTSI also doesn't look meaningful with early CPO participation (eg. no mention in ER aside from NPO, and removal from Ayar website). So I wonder who players like $AMD is going to go with for Helios (eg. Sivers + Ayar more likely candidate now)? Btw, this is not bearish AAOI because they have too much demand for optical transceiver business. Just more bullish on the existing few qualified CPO laser names that have capacity. 2. Demand imbalance and bottleneck for InP lasers / optical transceivers. AOI's CEO stated kinda supported that when they said: "The customer demand is 20%-40% higher" than expanded built out capacity. "We are getting this kind of demand from several big customers almost every week. Lasers are the biggest bottleneck right now for the transceiver business" 3. China being years away from having CPO DWDM specification lasers. I covered this earlier when looking at CPO competition from channel checks. But AAOI confirming that China is "easily at least two, three years or even longer from having CPO lasers is incredible tread through on defensibility Western laser positioning in the CPO laser chokepoint. TLDR: - High demand imbalance for CW lasers and optical transceivers. - $AAOI not in first-gen CPO due to capacity constraints (not exactly bearish AAOI because they have too much demand for their optical transciver business, but even better news for the few independent players with capacity coming online like $SIVE) - China years behind in CPO lasers.
-
AAOI财报验证光模块需求远超供应，产能爬坡中，看好板块传导。
以下是关于 $AAOI 财报的简要要点： - 预计超大规模客户将在未来几周内完成 1.6T 产品的全面认证（有助于收入爬坡 #2，时间线） - 继续认为 AOI 将拥有美国最大的 AI 数据中心光收发器产能（在竞争对手可能被禁时期重申雄心） - 预计磷化铟(InP)产能设施将于 2027 年初投产（进一步爬坡的时间线参考） - 总产能接近每月 20 万颗/单位，年底 800G/1.6T 达 65 万颗/单位。2027 年底达 93 万颗/单位（这是我想要看到的爬坡） - “增加外部光源(ELSFP)的制造产能。这是用于共封装光学(CPO)的”。我们预计今年晚些时候及 2027 年扩大生产，最终在 2028 年达到每月约 40 万件（需要时间将其建模为收入） - “如前所述，我们多年来一直内部制造激光器。这使我们避免了影响行业其他公司的短缺”（CW/EML 激光器短缺期间的垂直整合看多逻辑） - 我们相信未来 CPO 将继续推动对高功率激光器的需求增加（CPO 板块论点验证） - “长期目标是将非公认会计准则毛利率恢复到 40% 左右” - “第二季度末现金等价物总计 5.088 亿美元” 我需要再次确认 ATM 是否完成 - “我们交付收入的能力，特别是 800G 产品，目前受限于我们的生产能力”“如果我们能生产更多，我们现在就能发货更多” 需求 > 供应验证。 - “大部分增加的产能将在美国。即便如此，让我说，正如我一直强调的，这还不足以应对客户需求。客户需求高出 20%-40%。” 整个板块的光子学需求验证惊人，阅读 $LITE, $SIVE / $JBL 等公司的传导效应令人惊叹。 - “在未来两三年内不会，尤其是需求如此之大。好吧？即使结合 AI，$LITE, $COHR, $AVGO 加在一起，未来几年满足客户需求仍然非常困难” 更多光通信板块需求验证。 - CPO 时间线：“如果你说的是 CPO 市场的高产量制造商，我会说是明年第三季度末左右”以及“我们已与至少五家客户密切合作” 如果你关心当前财报（我并没有仔细看） 营收：1.91 亿美元 vs 1.90 亿美元 每股收益：0.06 美元 vs 0.02 美元 简而言之：激光器 + 光通信板块需求传导非凡。某种程度上支持 Lumentum CEO 关于激光器短缺比内存短缺更严重的说法。 2027 年产能爬坡按计划进行。要映射拐点期与时间线，大约在明年年初，正如他们之前的财报电话会议所述。 AAOI 现在拥有客户。限制在于制造足够的激光器和收发器。
英文原文
Just some TLDR notes on $AAOI earnings: - Expects full qualification of 1.6T products by their hyperscaler customer within next couple of weeks (helpful revenue ramp #2, timelines) - Continues to believe that AOI will have the largest AI DC transceiver production capacity in the US (reiterating ambitions during a time when their competitors might get banned) - Expects facilities toward InP capacity to come online in early 2027 (timeline FYI in terms of further ramp) - Total capacity is approaching 200,000/u per month, EOY 650,000/u per month of 800g/1.6t. EOY 2027, 930,000/u (this is the ramp i want to see) - "increase our manufacturing capacity for our external light source or ELSFP. That's for co-packaged optics or CPO". we anticipate ramping production later this year and into 2027, ultimately culminating in about 400,000 pieces per month in 2028 (need some time to model this into revenue) - "As we have mentioned before, we've been manufacturing lasers internally for many years. This has allowed us to avoid some of the shortages that have affected others in the industry" (vertical integration bull case during CW/EML laser shortages) - We believe that in the future, CPO will continue to drive increased demand for high-power lasers (thesis validation on CPO sector) - "to our long-term objective of returning non-GAAP gross margins to around 40%" - "We ended the second quarter with $508.8 million in total cash equivalents" I need to double check if the ATM finished or not - "our ability to deliver revenue in general, and specifically when it comes to 800G products, is limited by our production capacity right now" "If we could produce more, we could ship more right now" Demand > Supply validation. - "Most of the increased capacity will be in U.S. Even so, let me say that, like I keep emphasizing, that is not good enough for the customer demand. The customer demand is 20%-40% higher." Unholy photonics demand validation across the whole sector, read through for $LITE, $SIVE / $JBL, and others is amazing. - "Not in the next two, three years, especially the demand is so big. Okay? Even combined AI, $LITE, $COHR, $AVGO all together, it's still very tough to meet the customer demand in the next few years" More optical sector demand validation. - CPO Timelines: "If you're talking about really high volume manufacturer [for CPO market], I would say more like the late Q3 next year" and "We have been working very close with at least five customer" If you care about current earnings (which I'm not really looking at closely) Revenue: $191M vs. $190m EPS: $.06 vs. $.02 TLDR: Extraordinary demand across the laser + optical sector read through. Kinda supporting Lumentum CEO statement that laser shortage is worse than memory shortages. 2027 capacity ramp on track. To map inflection period with timelines, would be around early next year, as stated in their previous earnings call. AAOI has the customers now. Limitation is making enough lasers and transceivers.
-
禁令利好西方光模块厂商，AAOI等1.6T+玩家受益。
@Lseperlee 对我来说，$AAOI 是 2027 年上半年末的放量玩家，因为大约那时他们将达到每月 4.71 亿美元营收预测的拐点。近期起草的禁止英诺赛科(Innolight)等公司新光模块的光模块禁令，增加了 $AAOI、$SIVE/$JBL、$LITE、$COHR 等公司在 1.6T+ 项目上的权重。尤其是如果该禁令在 2026 年最终确定。由于可能会出现价格上涨，且需求将更集中于少数西方玩家产能。
英文原文
@Lseperlee $AAOI is an end of H1 2027 volume ramp player for me, since around then is when they hit inflection point of $471m/month revenue projections. Recent drafted ban on new optical transceivers coming from Innolight and others, increase weight on players like AAOI, $SIVE / $JBL, $LITE, $COHR for their 1.6T+ programs as well. Especially if finalized in 2026. Since there's likely going to be price hikes, and more demand concentration over capacity from the select few Western players.
-
AI激光器供应危机加剧，验证AAOI等标的瓶颈逻辑。
$LITE CEO Michael Hurlston 在 RAISE 峰会上警告称，AI 数据中心（AI DCs）用磷化铟(InP)激光器的供应缺口： 正面临比存储芯片更严重的供应链危机。 凭借 Lumentum 的 5 座 InP 晶圆厂，其出货量将比客户需求低 30% 以上。 这在目前的电吸收调制激光器(EMLs)上尤为明显，但随着共封装光学(CPO)的推进，已扩展至连续波(CW)激光器。 我一直看好 $AAOI、$SIVE、$LITE 和 $COHR 带来的激光器卡脖子+瓶颈逻辑。很高兴这一论点开始得到验证。
英文原文
$LITE CEO Michael Hurlston at the RAISE Summit warned that the supply gap for InP lasers for AI DCs: Is facing a more severe supply chain crisis than memory. And with Lumentum's 5 InP fabs, shipments would be more than 30%+ below customer demand. This is especially visible with EMLs today but is already expanding to CW, especially as CPO ramps. I've always been a fan of the laser chokepoint + bottleneck from $AAOI, $SIVE, $LITE, and $COHR. And glad this thesis is starting to see validation.
-
亚马逊资本支出上调及算力短缺证实，AXTI 产能扩张且供不应求，看多 AI 半导体及光通信供应链。
几条财报摘要，重点是我看好的 $AXTI 和 $AMZN： 亚马逊： - 将 2026 年资本支出上调至 2200 亿美元（此前为 2000 亿美元），部分原因是内存成本上升，这对 $MU 和三星是利好。 - 即使达到 2200 亿美元，亚马逊的产能仍无法满足 2026 年的所有需求；Jassy 预计 2027 年情况相同。 - 大多数 2027 年的新增产能已被预订，2028 年的大量产能也已预订。 主要浏览了上游半导体板块。$GOOGL、$META、$AMZN 和 $MSFT 均指出算力短缺。 几周前关于 Meta 等公司“算力过剩”以及超大规模云厂商削减支出的所有叙事……全是胡扯。 亚马逊财报对 AI 半导体交易非常看多。 AXTI： - AXT 计划在 2026 年将磷化铟(InP)产能翻倍，2027 年再翻倍。 - 预计这将使 AXT 成为“迄今为止全球最大的磷化铟生产商”——冲鸭。 - 第二季度营收为 4760 万美元，创 AXT 历史单季新高（来自数据中心应用的 InP 营收创纪录达 3070 万美元）。 - 营收环比增长 77%，同比增长 164%。 - InP 营收-产能目标：2026 年底每季度 6000 万美元。 - 2027 年底每季度 1.3 亿美元。 由于管理层表示他们将“寻找任何方式增加产能扩张”，1.3 亿美元的目标可能会进一步提高。 管理层称报告中的积压订单仍远高于 1 亿美元，但该数字已不能反映所有可用需求。 “无论我们增加产能的速度多快，客户需求持续超过供应。” 800G/1.6T 正在驱动当前周期，而 NPO/CPO 将其延伸至 2027 年之后。 此外，他们的目标是 50% 以上的毛利率：“我们绝对应该瞄准一个以五开头的数字。” 中国需求翻倍有余，且与 Casela、$COHR 和 $LITE 的协议并未实质性推动第二季度业绩。 这甚至还没有考虑我预测的随着 InP 衬底瓶颈加剧带来的巨大平均售价(ASP)上涨。 摘要： - 亚马逊算力需求过大，需要资本支出来满足，因此上游半导体起飞。 - AXT 是全球最大的 InP 衬底供应商，高毛利率，产能扩张，且供应跟不上需求。 看多来自亚马逊的需求端+资本支出。看多上游光通信供应链，因为需求过大。
英文原文
Few earnings TLDRs with my favorite $AXTI and $AMZN: Amazon: - Raised 2026 capex to $220B vs. prior $200B (partly due to higher memory costs, which is bullish on $MU to Samsung) - Even at $220B, Amazon will not have enough capacity to meet all 2026 demand; Jassy expects the same in 2027. - Most incoming 2027 capacity is already reserved, with substantial 2028 capacity also reserved. Mostly read through on upstream semis. $GOOGL, $META, $AMZN, and $MSFT all identified compute shortage. All the narratives a few weeks earlier was "excess compute" from Meta and others + hyperscalers cutting back on spend... All BS. Amazon earnings was very bullish on AI semi trade. AXTI: - AXT to double InP capacity during 2026. Then double again in 2027. This is expected to make AXT "by far the largest indium phosphide producer in the world." - LFG - Q2 rev was $47.6M, the highest quarterly revenue in AXT history (InP revenue reached a record $30.7M, from DC applications.) - Revenue increased 77% sequentially and 164% year over year. - InP revenue-capacity targets: $60M per quarter exiting 2026. - $130M per quarter exiting 2027 That $130m target could be hiked too since management stated they find "whatever ways to increase that capacity expansion" - Management said the reported backlog remains well above $100M, but that number no longer reflects all available demand. "Customer demand continues to outpace supply, no matter how fast we add capacity." 800G/1.6T is driving the current cycle, while NPO/CPO extends it beyond 2027. Also they're targeting 50%-plus gross margin: "We should definitely be targeting a number that begins with a five." China demand more than doubled, and their agreements with Casela, $COHR and $LITE did not materially drive Q2. This is not even considering my projected massive ASP hikes yet as InP substrates get more bottlenecked. TLDR: - Amazon too much compute demands, needs capex to fufill it, so upstream semis go brrr. - AXT world largest InP substrate supplier, high gross margins, expansion, and supply can't keep up with demand. Bullish on demand side from Amazon + capex. Bullish on upstream optical supply chains from too much demand.
-
AXTI获两大光学巨头巨额产能预留订单，信号积极。
@wz2013 $AXTI 此前已与 $COHR 签订长期协议(LTA)，并支付了 2230 万美元的预留金。今天又与 $LITE 签订了 LTA，总计 8700 万美元（4350 万 + 4350 万）再次用于预留产能。考虑到这两家都是领先的光学玩家，这似乎是积极的信号。合同定价等具体细节尚不清楚，我们将拭目以待。
英文原文
@wz2013 $AXTI secured LTA with $COHR earlier, with a $22.3M reservation payment. As well as a LTA with $LITE today, totaling $87M ($43.5M + $43.5M) again to reserve capacity. Considering that these are both of the two leading optical players, seems positive. The actual details such as pricing of the contracts aren't known, so we'll find out more.
-
澄清AMD是AAOI首批CPO客户，并指出LITE/COHR/SIVE为CPO激光器核心标的。
@Thomus0x 呃，Rosenblatt 6月30日的研报指出 AMD 是 $AAOI 共封装光学(CPO) 最可能的首批客户。我不会说他们离实现还遥遥无期。 根据摩根士丹利最近的研报，$LITE / $COHR / $SIVE 目前在 CPO 激光器可见性方面看起来就是你最看好的前三大标的。
英文原文
@Thomus0x eh, Rosenblatt June 30 note identified AMD as the likely first $AAOI CPO customer. I wouldn't quite say they aren't remotely close. $LITE / $COHR / $SIVE just look like your top 3 right now in terms of CPO laser visibility per the recent Morgan Stanley note.
-
AI算力瓶颈从CPU扩展至全产业链，长期协议锁定需求，利好瓶颈环节投资。
$INTC 和 $AMD 将与中国客户签署针对 AI 数据中心 (AI DCs) 的 CPU 长期协议 (LTAs)（路透社）。据消息源称，年初以来部分 CPU 产品在中国的价格已上涨超过 40%。部分产品环比涨幅超过 10%。受 AI 推理 (AI inference) 的 CPU 配比影响，CPU 本身已是瓶颈。但更广泛的长期协议 (LTAs) 趋势似乎正从以下领域显现：内存方面，$MU、三星、$SNDK 和 SK 海力士签署 DRAM/NAND 长期协议；光子学方面，$LITE、$COHR 签署 EML 长期协议。且 Trendforce 近期报告称 $AMD 和超大规模云厂商正追求 CW 长期协议。我相信从 MLCC 到基板等更多领域也是如此。瓶颈投资者 +1……如果拥有跨越多年的“提货或付款”需求，很难成为“破裂的泡沫”。
英文原文
$INTC and $AMD to sign CPU LTAs with Chinese customers for AI DCs (Reuters). - Prices of some CPU products have risen more than 40% in China since the start of the year from sources. - Month-on-month increases topping 10% for some products CPUs were already a bottleneck, following CPU ratios due to AI inference... But the broader trend of LTAs seems to be appearing from: - Memory, with $MU, Samsung, $SNDK, and SK Hynix signing DRAM/NAND LTAs. - Photonics, with $LITE, $COHR signing EML LTAs. And recent Trendforce reports that $AMD and hyperscalers are now pursuing CW LTAs. And I'm sure there's many more from MLCCs to all the way to substrates. +1 for the bottleneck investors... hard to be a "bubble that pops" if you have take or pay demand spanning multiple years.
-
摩根士丹利将SIVE列为CPO核心玩家，机构正利用其上市前的流动性错配。
@afasano23 摩根士丹利在3天前的研报中将 $SIVE 与 $LITE 和 $COHR 并列为三大核心共封装光学(CPO)激光器玩家。富达研究、摩根大通等机构已开始积极建仓。他们最近以57瑞典克朗的价格完成了一轮超额认购的机构融资。这一切都发生在美国纳斯达克上市之前。我个人认为，目前相对于远期收入存在短期流动性错配，我确信机构正在利用这一点。
英文原文
@afasano23 Morgan Stanley listed $SIVE as the three core CPO laser players alongside $LITE and $COHR in their note 3 days ago. Fidelity Research, JP Morgan and others have started to take active positions. They recently raised an oversubscribed institutional round at 57 SEK. This is all ahead of US NASDAQ listing. I personally see short term liquidity disconnects relative to forward revenue around now and I'm sure institutions are capitalizing on it.
-
POET证实光学巨头遭抛售，预示市场将经历去杠杆回调。
@meikozz_2026 我认为基本面没有错。市场可能会不时出现大幅回调，以清洗掉杠杆和保证金，随后才会继续上涨。 而且这个月似乎就是这样的时间节点？ $POET 证实你们提到的大型光学巨头如 $LITE、$COHR 已被完全抛售。
英文原文
@meikozz_2026 I don't see any fundamentally wrong. There's probably going to be large corrections from time to time flush out margin/leverage before things move higher. And this month seems like that time of year? $POET confirmed your big optical giants like $LITE, $COHR are completely sold
-
SIVE受算法忽视但获大行认可，博主看好其补涨潜力。
@talethdabm89 感觉算法交易经常忽略 $SIVE，尽管在 CPI 数据公布后 $LITE 和光学板块略有复苏。尤其是因为它在某个瑞典随机交易所交易，但偶尔也会补涨。话虽如此，它肯定已进入机构视野，特别是因为摩根士丹利 (MS) 昨天将其与 $LITE 和 $COHR 并列为三大领先共封装光学 (CPO) 激光器公司。只是在等待事态发展，股票不会每天都直线上涨。
英文原文
@talethdabm89 Feels like algos often miss $SIVE, after slight $LITE / optical sector recovery after CPI print. Especially bc it's trading on some random Swedish exchange, but catches up on random days. That being said it's definitely on institutional radar, especially since MS put it next to $LITE and $COHR as the three leading CPO laser companies yesterday. Just waiting for things to play out, stocks don't move in a straight line up every day.
-
摩根士丹利研报梳理CPO产业链各环节关键参与者。
摩根士丹利今日发布关于共封装光学(CPO)的研报。关键参与者包括： - 激光供应：$SIVE、$COHR 和 $LITE - 交换平台：博通(Broadcom) 和英伟达(Nvidia) - 光学引擎与光子学：Lightmatter、Ayar Labs、Marvell/Celestial 和 POET - 硅光子学(Silicon Photonics)：$TSM、$GFS 和 $TSEM https://t.co/mmz6y0J3cp
英文原文
Morgan Stanley note on CPO today. Key participants include: - $SIVE, $COHR, and $LITE in laser supply - Broadcom and Nvidia in switch platforms - Lightmatter, Ayar Labs, Marvell/Celestial, and POET in optical engines and photonics, - $TSM, $GFS, and $TSEM in silicon photonics https://t.co/mmz6y0J3cp
-
AXTI与Coherent签3年晶圆协议，获2200万美元预付款。
$AXTI 与 $COHR 签署为期 3 年的晶圆协议。 “Coherent 将向 AXT-Tongmei 预付 22,288,500 美元，以换取承诺的供应产能。” https://t.co/nTkyJSMo96
英文原文
$AXTI signs 3-year wafer deal with $COHR. "Coherent will make a prepayment of $22,288,500 to AXT-Tongmei in exchange for a committed supply capacity." https://t.co/nTkyJSMo96
-
OE Solutions是韩国自主光子学玩家，风险高于SIVE，Q3-Q4或更有趣。
最近我收到了很多关于 OE Solutions (138080) 的询问。 以下是我目前的研究/想法： 这是一家小型韩国光收发器公司，类似于 $AAOI。 他们已成为全球少数 EML（电吸收调制激光器）玩家之一（例如 $COHR、$LITE、三菱、Source、住友），拥有稀缺的用于 800G/1.6T 的 100G EML 激光器产能。 OE 似乎正试图制造完整的光收发器，而不仅仅是 EML。他们还有成品 ELSFP CPO（共封装光学）产品，采用 UHP CW（连续波）激光器，预计 Q3 开始送样。 同样，OE 似乎也在构建完整的 ELSFP，而不是仅出售 CW 激光器裸片，从而获取更多市场份额。 所以你可以将其视为韩国版 AAOI，但主打 EML 而非 CW，且产能/资质较少。正在追赶世界其他玩家。 然而就时间线而言： 1. 23dBm 冷却 ELSFP 样品于 2026 年 Q3 开始 2. 800G 的销售基础，以及 2027 年 1.6T “全力”推进 3. 2027 年下半年至 2028 年上半年，其 ELSFP 可能进入量产。 而且他们似乎正在研发 200G EML 能力，其 2025 年投资者简报中提到的“100GBaud EML / 200G PAM”似乎很有前景，鉴于其 IP/演示。 ELS 刚刚发布，Q3 开始送样。800G/1.6T 光收发器也可能在 2027 年。 所以这基本上是韩国的自主光子学玩家，正在追赶 $LITE、$AAOI 和更大的玩家。 （披露：我持有 OE Solutions (138080) 头寸。这是出于信息目的的基本面研究，非财务建议）。 关于 OE 的估值： 1. 这些增长领域似乎还没有确认的客户。 2. 可能没多少人理解他们在构建什么。 3. 良率数据相当不确定 1. 客户：我们实际上正处于严重的 EML/CW 激光器短缺中，因此任何独立产能都会备受追捧。我个人认为他们在这里不会很难找到客户。我假设他们生产的任何东西都可能被买断，并会得到韩国的额外支持。 2. 机构支持：可能不多，因为其市值+韩国上市不符合许多美国机构的门槛。我也不认为很多人理解他们在构建什么。 3. 良率/产能：OE 披露的晶圆/模块利用率低（我记得大约是 31% 未充分利用），所以在需要资本支出之前，他们有足够的材料收入可以产生。 我也不确定 EML/CW 和其他良率。可能需要去问公司。 这是家随机垃圾公司吗？不。它从事光收发器业务已超过 20 年，在美国和荷兰有研发。 但他们整个 AI 增长领域似乎明年才会发生，主要取决于产能/良率。 我个人认为 EML/CW 技术如果作为收购目标，可能比当前市值值钱得多。 特别是对于想要垂直整合 EML 用于可插拔模块和 CW 激光器用于 CPO 的大玩家。 市场可能在等待 Q3 送样后更多关于资质的确定性，或盈利预测公告。 想法 TLDR： 我的一些朋友去年讨论过，可能太早了。两个月前看到它有很多评论，仍然太早。 我认为现在仍然太早，但 Q3-Q4 后期可能更有趣。我个人认为它比主要 CPO 玩家如 $SIVE 风险大得多，后者已嵌入 Ayar、$JBL、$GFS 和许多其他超大规模供应商。也有 Win Semi 等降低量产风险。 因为 OE Solutions 看起来像是一个新玩家，试图为光收发器构建一个 $AAOI，但拥有自主 EML 和 CW 激光器生产用于 CPO 产品。 关于客户+量产爬坡有很多未解问题，存在重大风险。 但如果你相信韩国能构建出 800G/1.6T 光收发器 EML 供应链和带 CW 激光器的 ELSFP。 通过 OE Solutions，可能值得看一眼。仍在研究该公司，只是初步想法。
英文原文
I've been getting a lot of questions about OE Solutions (138080) recently. Here's my research/thoughts so far on it: They're a small Korean optical transceiver company, similar to $AAOI . And they've become one the few EML players in the world (eg. $COHR , $LITE , Mitsubishi, Source, Sumitomo), with scarce 100G EML laser capacity for 800G/1.6T. OE appears to be trying to make the full transceiver, not just the EML. They also have finished ELSFP CPO products, with UHP CW lasers, which is sampling Q3. Likewise, OE also seems to be building out the full ELSFP, rather than selling CW laser dies, so that's more market share. So you can think of it as Korean AAOI but EML instead of CW, and less capacity/qualifications. And playing catch-up to the rest of the world. However in terms of timelines: 1. 23dBm cooled ELSFP samples start in Q3 2026 2. Sales base for 800G, and 2027 1.6T "full force" 3. Late H2 2027, H1 2028 onward probably their ELSFP enters the volume production. And it seems they're working on 200G EML capability from their investor snipper 2025 OE IR snippet referenced “100GBaud EML / 200G PAM". This seems promising given their IP/demos. ELS has just been unveiled recently, sampling starts Q3. 800G/1.6T Optical transceivers are also likely 2027. So this is basically Korea's sovereign photonics player, playing catchup to $LITE , $AAOI , and the bigger players. (Disclosure: I have positions in OE Solutions (138080). This is fundamental research for informational purposes, not financial advice). As for OE solution valuations: 1. Doesn't seem like there's confirmed customers yet for these growth verticals. 2. Probably not many people understood what they're building toward yet. 3. Yields data kinda uncertain 1. Customers: We're actually in a major EML/CW laser shortage, so any independent capacity will be sought after. I personally don't think they'll have a hard time finding customers here. I would assume anything they make might get bought out and would get extra support from Korea. 2. Institutional support: Probably not much since it doesn't meet threshold for many US institution given MC size + KR listing. I also don't think many people understood what they're building yet. 3. Yields/Capacity: OE's disclosed wafer/module utilization is low (i remember was around 31% underutilized off the top of my head), so there's enough material revenue they can generate before they need to spend on capex. I'm also not sure about EML/CW and other yields. Probably need to go ask the company. Is this some random crap co? No. It's been doing optical transceivers stuff for more than 20Y, has R&D in the U.S. and Netherlands. But their entire AI growth vertical seems to happen next year, and hinges mainly around capacity/yields. And I personally think the EML/CW tech is probably worth a lot more than their current MC, if it were an acquisition target. Especially from a larger player that wanted to vertically integrate EML for pluggables and CW lasers for CPO. Markets are probably waiting on more certainty around qualifications after Q3 sampling or earnings projections announcements. TLDR on thoughts: Some of my friends discussed this last year, was probably way too early. Saw it got many comments 2 months ago, still too early. I still think now is early, but later in Q3-Q4 might be more interesting. I personally think it's a lot higher risk than a major CPO player like $SIVE, that's embedded in Ayar, $JBL , $GFS , and many other hyperscaler suppliers. Which also has Win Semi and others de-risking volume ramp. As OE Solutions looks like a new player trying to build out an $AAOI for the optical transceivers but sovereign EML and CW laser production for CPO products. And there's a lot of answered questions around customers + volume ramp, which presents material risk. But if you believe Korea can build out an 800G/1.6T transceiver EML supply chain and ELSFP with CW lasers. With OE Solutions, it might be worth taking a look into. Still researching the company tho, just initial thoughts.
-
感谢中文社区支持，重申对激光及光子学板块的长期看好。
我衷心感谢中文社区对我最看好股票的投资理念进行的深入分析！ 总体而言，像 $AAOI 和 $SIVE 这样的激光公司是我的个人最爱，因为它们拥有巨大的营收扩张空间。它们不仅可以销售激光器，还能制造完整的光模块，以及各种光引擎或 ELS（外部光源）组件。 或者，像 $COHR 那样，它们甚至可以向上游延伸至基板制造，从而实现垂直整合，并持续提升其毛利率和总潜在市场 TAM。 这里的关键部分在于率先准确锁定主要投资主题——毕竟，去年许多人甚至不认为“光子学”能成为一个真正热门的概念。 我认为最让大多数人惊讶的是，我们现在仍处于极其早期的阶段。绝大部分的营收增长直到明年，即 2027 年上半年甚至下半年才会真正启动！ 话虽如此，看到中文社区持续且坚定的支持真的让我感觉很棒。我将竭尽全力不辜负大家给我的绰号：“白发股神”。
英文原文
I'm deeply grateful to the Chinese community for the in-depth analysis of my investment ideas on my most favored stocks! Overall, laser companies like $AAOI and $SIVE are my personal favorites, because they have tremendous room for revenue expansion. They can go beyond just selling lasers to manufacturing complete optical modules, as well as various optical engines or ELS (external light source) components. Or, like $COHR, they can even extend upstream into substrate manufacturing, thereby achieving vertical integration and continuously boosting their gross margins and total addressable market TAM. A big part of the key here lies in being the first to accurately pinpoint the main investment theme—after all, last year many people didn't even think "photonics" could become a truly hot concept. And I think what will surprise most people the most is that we're still in an extremely early stage right now. The vast majority of revenue ramp-up won't truly kick off until next year, in the first half or even second half of 2027! That said, seeing the ongoing and unwavering support from the Chinese community really makes me feel great. I'll do my utmost not to let down the nickname everyone gave me: "White-Haired Stock God."
-
认为NVDA CPO生态第一代可能大量以SIVE为主供。
回复 @OGCapital25 @Chi_w_wong：Celestial 和 Lightmatter 尝试多源采购是预期之内。 但我猜第一代里，$NVDA CPO NVLink 生态很多会由 $SIVE 单一供应/主供应。 英伟达自己也有与 $LITE 和 $COHR 的项目。
英文原文
@OGCapital25 @Chi_w_wong It's expected Celestial and Lightmatter try and multi source. But maybe for gen-1 my guess is a lot sole source / primary source with $SIVE for the $NVDA CPO NVlink ecosystem. Nvidia has their own program with $LITE and $COHR.
-
推测Innolight等未垂直整合激光器的可插拔玩家可能使用SIVE。
回复 @WuKongWAGMI：我能想到的主要可插拔玩家里，只有少数没有像 $LITE 和 $COHR 那样垂直整合激光器。 所以 Innolight 是可能的。 $SIVE 用了复数暗示有多个玩家，所以很可能还有几个。
英文原文
@WuKongWAGMI There’s only a few major pluggable players that I can think of that don’t vertically integrate lasers like $LITE and $COHR. So Innolight is possible. $SIVE hinted at multiple players since this plural, so there’s likely a few more.
-
回顾AAOI/AXTI早期被FUD，如今类似CPO转折正在SIVE/Foci上重演。
当我在 $AAOI 约20-30美元做多时： 我以为 $AMZN 和 $MSFT 正在为其 ASIC 项目认证特定光收发器。 结果它更可互换、更可大规模生产。 无论如何，很高兴我关于 $LITE、$AAOI、Innolight、$COHR、$AXTI 的 thesis 表现这么好。 记住：当 $AAOI 在20-30美元时，X 上所有人都说“管理层诈骗”…… 或者在 $AXTI 12美元时说“诈骗公司”。 FUD 非常极端。 现在感觉又像似曾相识……做多下一轮 CPO 架构转变，比如 $SIVE 或 Foci？然后收到同样评论。 我们会看看我的 CPO 多头是否会像 Shunsin 对 Innolight、或 $SIVE 对 $LITE 那样兑现。 无论如何，那些名字现在都已经上涨数百到数千个百分点。
英文原文
Back when $AAOI was ~$20-30 when I went long: I thought $AMZN and $MSFT were qualifying specific optical transceivers for their ASIC programs. Turns out it’s more interchangeable/mass producible. Regardless, glad my thesis on $LITE, $AAOI, Innolight, $COHR, $AXTI played out so well. Keep in mind: everyone on X was saying “scam management” with $AAOI back at $20-30… Or “scam company” with $AXTI at $12. FUD was pretty extreme. Feels like dejavu again… going long on the next CPO architectural shift like $SIVE or Foci? And getting the same comments. We’ll see if my CPO longs play out the same way like Shunsin does with Innolight or $SIVE does with $LITE. Either way all of those are now up hundreds to thousands of percent.
-
Sivers为CPO玩家制造架构独特的DFB激光器，是咽喉要道且具高定价权。
光子学是复杂微妙的，用ChatGPT/Gemini会让你忽略其中所有的细微差别： 1. $SIVE实际上是一个咽喉要道，部分也是一个瓶颈。 它之所以是咽喉要道，是因为领先的CPO/光学超大规模玩家都要经过Sivers，很可能是：Ayar、Celestial、Lightmatter、Lightelligence、Poet。 如果你去掉Sivers，你实际上无法制造他们的一些产品，并使路线图延迟数年。 尽管许多是单一/主要来源，但正在朝着多来源方向发展。 至于瓶颈论点：Win Semi是扩大激光生产的瓶颈。 但是……微妙之处在于，当你拥有未来几年的产能分配时，如果玩家们争夺成品激光器的分配，你本身就成为瓶颈的一部分。 这就是人们错过的关于产能分配动态的微妙之处。 这就像说当Kioxia生产全部NAND时，$SNDK不是NAND瓶颈一样。 但当Sandisk拥有最终产出供应控制权时，他们就成为瓶颈+拥有所有定价权。 Sivers在分配的前提下控制CW激光器的产出供应，正如$LITE财报所示，CW激光器目前是瓶颈的，因为每个人似乎都在努力生产EML。 2. 就像大语言模型总是使用破折号一样。 你能看出人们什么时候用AI——当他们总是使用同样的「CW是一个愚蠢的可互换激光器」论点，或者在混淆不同架构后比较「功率」规格时。 这就是为什么你的「分析师」使用AI会一次又一次地犯错。 有CW激光器……然后有Sivers用DFB激光器实现的特定架构设计。 如果你比较$LITE与Sivers的功率规格，孤立来看Lumentum赢了。但它们是完全不同的激光架构。 所有领先的CPO玩家如Ayar，选择$SIVE是因为其高功率、低热、激光阵列的架构原因。$JBL的1.6T LRO还利用Sivers激光器建立了最具戏剧性的护城河之一，他们的炉边谈话中引用了这一点。 如果你认为CW激光器可以和Sumitomo/Furukawa及其他厂商的可互换，可以即插即用……我无话可说。 再次强调：$SIVE为领先的CPO玩家制造架构独特的CW激光器。 3. 我不确定需要说多少次： $SIVE在2024-2025年一直在走开发合同路线。人们使用TTM收入或以前的市销率指标是完全错误的指标，因为2027年才有量产爬坡。 这和$AAOI在2027年上半年量产爬坡一样。 $AEHR在资质认证后量产爬坡。 $LPK在资质认证后量产爬坡。 这只是半导体行业缺少资质认证周期以及对当前财务建模的问题。 至于$LITE的比较（也是我去年长期持有的）： $LITE最初确实是销售激光裸片，然后才收购Cloud Lite和其他下游光学引擎组件。 这就是$SIVE今天的处境——从CPO的激光咽喉要道起步： 人们正基于非常孤立的TAM预测来建模激光收入。与此同时Sivers正在通过并购来扩展TAM预测的收入。 这不是简单的台湾公司组件FAU+爬坡估值建模。 既然激光公司如$LITE、$COHR以向下游扩张使激光更有价值而闻名，然后事后垂直整合（晶圆厂、封装）。 同样，Sivers在这些公司成为十亿美元公司之前就与他们合作过。我有高度信心知道他们知道该收购什么来扩展ELS/光引擎堆叠+可插拔收发器的TAM。 只是很烦人，总有人不理解这些细微差别却对我的长仓指手画脚，说些错误的东西。 我遇到同样的情况说「$AXTI不是瓶颈！InP不需要！中国！」，当时股价是14美元。 现在是140美元。 我遇到同样的情况说「$AAOI要跌50%！」，当时是65美元。或者「AOI管理层有问题」，当时是30美元。 现在是170美元。 我遇到「$SOI没什么新东西」，当时是45美元。 现在是170美元。 我认为我是少数真正理解光子学细微差别的人之一，因为我确实预判了$LITE、$TSEM、Innolight、$AXTI、$AAOI、$SOI，这些在过去一年里表现超过光子学市场和整体市场。 现在我做多$SIVE。
英文原文
Photonics is nuanced and using ChatGPT/Gemini makes you miss all of it: 1. $SIVE is actually a chokepoint and partially a bottleneck. The reason it's a chokepoint is leading CPO/optical hyperscaler players go through Sivers, likely: Ayar. Celestial. Lightmatter. Lightelligence. Poet. If you take out Sivers, you literally can't make some of their products + delay their roadmap by years. As many are sole/primary source but are heading the direction on multi-source. As for the bottleneck argument: Win Semi is the bottleneck for scaling laser production. But... the nuance is when you have capacity allocated for the next few years. You become part of the bottleneck itself if players fight you for allocation of finished lasers. That's the nuance people miss with capacity allocation dynamics. It's like saying $SNDK is not part of the NAND bottleneck when Kioxia makes all of it. But when Sandisk has the ultimate control of output supply, they become the bottleneck + have all the pricing power. Sivers controls output supply of CW lasers given allocations, and as seen with $LITE earnings, CW laser is currently bottlenecked as everyone seems to be stuck producing EMLs. 2. Like how LLMs always uses em-dashes. You can tell when people use AI when they always use the same "CW is a dumb interchangeable laser" argument or compare "power" specs after conflating different architectures. That's why your "analysts" using AI will get this wrong over and over. There's CW lasers... and then there's a specific architectural design that Sivers achieves with DFB lasers. If you compare power specs with $LITE vs. Sivers, Lumentum wins in isolation. But they're completely different laser architectures. All the leading CPO players like Ayar, chose $SIVE for an architectural reason for high power, low thermal, laser arrays. $JBL 1.6T LRO also made one of the most dramatic moats cited by their fireside chat, using Sivers lasers. If you think CW lasers are interchangeable with Sumitomo/Furukawa, and others. And can be plug-and-play... i don't know what to tell you? Again: $SIVE makes architecturally unique CW lasers for leading CPO players. 3. I'm not sure how many times I need to say this: $SIVE for 2024-2025 has been going through development contracts. People using TTM revenue or former P/S metrics are using completely the wrong metrics, when there's volume ramp in 2027. It's the same with $AAOI which volume ramps in H1 2027. $AEHR which volume ramps after qualification. $LPK that volume ramps after qualification. This is just missing qualification cycles in semiconductors and how to model financials currently. As for the $LITE comparisons (which was also my long last year): $LITE literally started off selling laser dies before acquisition of Cloud Lite and other downstream optical engine components. This is where $SIVE is at today with starting off in the laser chokepoint for CPO: People are modeling laser revenue off very isolated TAM projections. Meanwhile Sivers is targeting M&A to expand revenue for TAM projections. This is not a simple component FAU + ramp valuation modeling over with a Taiwanese company. Since Laser companies like $LITE, $COHR are known to downstream expand to make their lasers more valuable, then vertically integrate (fabs, assembly) afterward. Again, Sivers worked with Ayar and these types of companies before they all became billion dollar companies. I have high conviction knowing they know what to acquire down the ELS/optical engine stack + pluggable transceiver for TAM expansion. It's just annoying when I get people who don't understand the nuances backseat commenting wrong things about my longs. I got the same thing about $AXTI is not a bottleneck! InP isn't needed! China! back at $14. Now it's $140 I got the same thing about $AAOI "is going down 50%!" back at $65. or "AOI management is shady at $30". Now it's $170 I got the "there's nothing new with $SOI" back at $45. Now it's $170. I think I'm one of the few who actually understands the nuances with photonics, since I did call out $LITE, $TSEM, Innolight, $AXTI, $AAOI, $SOI, that outperformed both photonics markets and overall markets over the past year. And now I'm long on $SIVE.
-
比较AAOI与SIVE：前者制造规模，后者独特IP和CPO供应商渗透。
$AAOI 更偏纯制造规模，我极度看多它们。 所以在我看来，它更像 Furukawa + Innolight？因此对收入爬坡极其看多。 $SIVE 则是纯粹独一无二的 IP，主要 CPO 超大云供应商似乎都使用它们，比如 Ayar/Celestial 等。 甚至 $JBL 也用 Sivers 做出突破性的 1.6T LRO 护城河。 Sivers 的上限很高，未来也总能像 $COHR / $AAOI 那样用资本开支做垂直整合。 但它们当前主要重点应该是创造尽可能大的 IP 护城河，并把制造外包以保持轻资本。 以后也总能垂直整合组装和激光晶圆厂。 我喜欢它们两个，但原因不同。
英文原文
$AAOI is more pure manufacturing scale and I'm extremely bullish on them. So it's more like Furukawa + Innolight in my view? So extremely bullish for revenue ramp. $SIVE is just pure one-of-a-kind IP, where major CPO hyperscaler supplier seems to all use them, like Ayar/Celestial and others. Even $JBL made groundbreaking 1.6T LRO moats with Sivers. Sky is the limit here with Sivers and they can always vertically integrate like $COHR / $AAOI down the road too with capex spend. But their main focus right now should just creating the largest IP moat possible + outsource manufacturing to keep capex light. Can always vertically integrate the assembly, laser fab down the road too. I like them both for different reasons.
-
从LITE/COHR部分轮动到SIVE/Foci，认为CPO是光子学超级周期中最有吸引力主题。
一个帅哥就算和 Clavicular 并排也更抢眼，但这不会影响任何基本面。 我上个月也像 Leopold 一样，削减了一些 $LITE、$COHR 敞口。 但我把它轮动到一个具体光学主题：$SIVE / Foci 这样的 CPO 名字。 整个光子学供应链正处于巨大超级周期的起点，而做多 CPO 作为架构范式转变，没有什么比这更有吸引力。 市场把两家公司等同于整个主题，然后一起卖掉所有相关东西。 不过对理解细节的人来说，这是很好的买入机会。 我仍认为 Lumentum 和 $COHR 有上行，只是如果只买股票，在当前价格下不太可能像其他名字那样快速翻倍。
英文原文
A good looking guy that would mog Clavicular side by side has no impact to any fundamentals. I cut some exposure too in $LITE $COHR like Leopold, last month. But rotated it to a specific optical theme with CPO names like $SIVE / Foci. The entire photonics supply chain is in the start of a massive supercycle and there’s nothing more compelling going long on CPO as an architectural paradigm shift. Markets conflate two companies as the entire theme and sell off anything with it. Great buying opportunity for people who understands the nuance though. I still think there’s upside for Lumentum and $COHR, just less likely to double at current prices as fast if you’re going shares only.
-
深度分析光子学供应链四只股票，强调TAM扩张和垂直整合逻辑，认为是长期核心持仓而非短期交易
当我看到像这样（而且很多）的来自散户投资者的评论时，我立刻认为他们缺乏技术深度。 我来逐一分析从$SIVE到$LPK的每家公司： 1. 光子学TAM（总可寻址市场）从$140亿增长到$1540亿，仅仅两年时间，而且它很可能会在2030年之后继续增长，因为它是下一代架构的首选。 它不会在1年内消失。它不会在3年内消失，这就是为什么$LITE的溢价越来越高，因为他们已经排产到2028年了。 $SIVE供应CW（连续波）激光器，高度绑定CPO（共封装光学）和现在的可插拔收发器，用于1.6T和3.2T... 适用于像$JBL、Ayar、Lightmatter、Lightelligence、$POET、$MRVL、Celestial和$AMD这样的预期公司。 这不是一个"交易"，它是下一代光子学的核心瓶颈和IP持有者。 而且作为未来几年的舒适持仓是很合适的，因为他们正在扩展成为下一个$LITE。 我个人看到的风险（既然他们已经与这么多玩家完成认证），主要是他们能从整体光学超级周期中捕获多少TAM（市场空间）。（以及Win Semi产能爬坡的潜在风险，但Win体量很大所以我可以放心睡觉）。 因为仅仅供应激光器不足以支撑估值。 是TAM向下扩展到制造整个ELS（外部激光源）或整个可插拔收发器，才让这些激光器公司如此有价值。 之后，他们可以向上垂直整合以扩大毛利率，像$COHR那样做激光代工甚至衬底级别的业务。 在我看来，这是非常不对称的风险/回报比，因为我们已经在$LITE身上看到过——他们从$20亿增长到$800亿。 2. $LPK——是下一代先进封装转向玻璃基板的最纯粹敞口，没有SKC Absolics混乱的财务问题。 几乎每家主要半导体公司从$INTC到三星都在采用玻璃基板。 $LPK基本上就是该瓶颈的$ASML，因为他们目前供应给全球约80%的玩家。 是的，设备供应商有"贸易周期"，比如$ASML，如果有更多晶圆厂资本支出，ASML就会增长。但如果出现低迷，这些往往表现不佳，也无法捕获之后发生的所有量产出货。 然而，如果市值是$6.5亿，他们正在实现$1-2亿收入，随着每个客户的量产出货增长，他们从玻璃基板周期中获得的收益可能会超过当前估值。 而且他们会有基本面支撑（因为越来越多的公司采用封装转型），这会维持他们的估值。 现在只是等待产能爬坡的时机而已。 3. $AAOI——这简直就是美国版的光子学$INTC。可以说Intel不是长期投资。 猜猜你们所有的光收发器是在哪里制造的？ 中国、泰国、马来西亚。如果你看看Innolight、Eoptolink、$FN和其他公司。 AOI正在建设最大的美国本土供应链，包括CW激光器代工以及800G、1.6T组装。 是的，这也有可插拔周期起伏。明年会有1.6T的浪潮，然后CPO会蚕食可插拔市场。 但由于他们在内部制造整个供应链，他们对其他细分市场有极大的选择性。而且像$NVDA的老一代GPU一样，会有主权数据中心对老一代可插拔收发器的需求，来自像$AAOI这样的厂商。 它很可能会继续上涨，因为它在2026年下半年达到每月$4亿+收入的目标。 一路上有很多不同的短期波动，比如$6亿的稀释。 4. $IQE——？？？这是西方世界最重要的外延晶圆玩家之一。 $MTSI不遗余力地偿还了IQE的债务，因为他们不能让IQE倒闭。$IQE还向$LITE供货。 目前世界在 Landmark评论提到的外延晶圆水平和InP衬底水平都存在瓶颈。 他们的财务数据虽然糟糕，但从原始账面价值和他们在整个西方供应链中的价值来看……完全支撑他们的估值。其他光学公司不会让他们核心的上游供应链倒闭。 因为这些价值数千万美元的材料出问题，会搞砸下游价值数十亿美元的产品。 再次强调，光子学是扩展AI所需的下一代架构。不是量子计算那种"还在开发中"的东西。 它就在这里，而且是$NVDA选择的架构。 如果几年后这些都涨了很多，我一点也不会惊讶。 那些认为"只是因为我提到了"就在3个月内一波流的 people，根本不知道他们在说什么。 机构最终会买入这些标的（就像Point 72买入$IQE那样），散户只会在估值已经涨了600%之后才知道。 真的应该在发表评论前做好研究： 这些都是需要深入供应链知识的前瞻性增长公司。
英文原文
When I see comments like this (and there are a lot) from retail investors: I immediately think they lack the technical depth. I'll walk through each one from $SIVE to $LPK: 1. Photonics TAM goes from $14B -> $154B In just two years time, and it's likely going to keep scaling past 2030 as it's the next generation architecture of choice. It's not going away in 1 year. It's not going away in 3 years, which is why $LITE premiums keep going higher since they're backlogged into 2028. $SIVE supplies CW lasers and is highly tethered to CPO and now pluggable transcivers for 1.6T and 3.2... For expected companies like $JBL, Ayar, Lightmatter, Lightelligence, $POET, $MRVL Celestial, and $AMD. This isn't a "trade", it's the core chokepoint and IP holder for the next generation of photonics. And it's a comfortable hold for the next few years as they scale to become the next $LITE. The risk I personally see (since they're already qualified with so many players), it's mainly how much TAM they can capture of the overall optical supercycle. (And potential risks with Win Semi volume ramp, but Win is massive so I can sleep tightly there). As just supplying lasers isn't enough to justify valuation. It's TAM expansion downward into making the entire ELS or entire pluggable transceiver that makes these laser companies so valuable. Then afterward, they can vertically integrating upward for gross margin expansion upward like $COHR into doing the laser fabs or even substrate level. And that in my view is a very asymmetric risk/reward ratio as we've already seen this done with $LITE as they went from $2B to $80B. 2. $LPK - Is the purest exposure, without the messy financials of SKC Absolics, as the next advanced packaging shift for glass substrates. Almost every single major semi company from $INTC to Samsung are adopting glass substrates. $LPK is basically $ASML of this chokepoint, since they supply to ~80% of the global players currently. Yes, there's "trade cycles" for equipment suppliers like $ASML, where if there's more foundry capex, ASML scales up. But if there's downturns, these tend to perform poorly, and don't capture all the volume ramp that happens after. However, if the MC is $650m and they're making $100-200M, revenue per costumer volume ramped, the amount they make from the glass substrate cycle will likely exceed current valuations. And they'll have baseline fundamentals (as more companies adopt the packaging shift), that keeps their valuation up. It's just a waiting game for volume ramp at this point. 3. $AAOI - This is literally $INTC but for America + Photonics. It's like saying Intel is not a long term investment. Guess where all your optical transcivers are made? China. Thailand. Malaysia. If you look at Innolight, Eoptolink, $FN, and others. AOI is building the largest Made in America supply chains for both CW laser fab, as well as 800g, 1.6T assembly. Yes, there are pluggable cycle ups and downs to this as well. There's going to be a wave for 1.6T next year, then CPO cannibalizes pluggables down the road. But since they make the entire supply chain in house, they have extreme optionality for other segments. And like $NVDA older gen-GPUs, there's going to be sovereign DC requirements for older gen pluggables from names like $AAOI. It's likely going to keep rising as it hits that $400m+/month revenue target H2 2026. There's just a lot of different short term volatility along the way like the $600m dilution. 4. $IQE - ??? It's one of the most important players in the Western word for epiwafers. $MTSI went out of their way to pay off IQE's debt because they can't have them going under. $IQE is also supplying to $LITE. The world is currently bottlenecked both on the epiwafer level from Landmark comments and InP substrate levels. Their financials were track but the raw book value, and value they hold to the entire Western supply chain... completely justifies their valuation. And other optical companies will not let their core upstream supply chain go under. As these tens of millions worth of materials would screw up tens of billions worth of downstream products. Again photonics is the next generation architecture required to scale AI. It's not Quantum where it's just "In development". It's literally here and the architecture of choice by $NVDA. I would not be surprised if all of these are a lot higher in 3-4 years time. People who think it's one and done in 3 months time "only because I mentioned it" don't know what they're talking about. Institutions would have bought up the name eventually (like Point 72 on $IQE) and retail would only find out after their valuations are 600% higher. Should really do the research before adding comments like these: These are all forward growth companies that require in-depth supply chain knowledge.
-
CPO市场将从零增长至910亿美元，欧洲、台湾、日本新玩家将主导CPO供应链变革。
人们好奇我为什么最近在关注非美国市场。 为什么？因为共封装光学(CPO)是我排名第一的主题性看多方向。 市场尚未意识到，光子学领域正经历一场突如其来的范式转变... 2025年，我是少数几个提前预判当前超级周期的人之一，当时买入的$AAOI约在$30、$LITE约在$300多、$AXTI约在$13...这些都是基于真实的业绩验证和其他人无法展示的thesis。 CPO市场将从约0增长到910亿美元的TAM机会。 高盛研究预计在未来1.5年内实现。 与此同时，整体光学市场将达到1540亿美元。 许多之前对当前光子学周期几乎没有任何敞口的企业： -> 欧洲企业拥有高端激光设计，如$SIVE或$SOI涉及衬底 -> 台湾企业如Foci (3363)、Nextronics (8147)、Shunsin (6451)等提供光学元件和代工服务 -> 日本企业涉及激光量产、衬底和化学品 突然之间成为了CPO的新主导力量。 至于美国玩家，目前敞口不大。但现有企业如$LITE、$COHR仍能从CPO中获得上涨空间，因为这是它们新的增长向量。 我对现有玩家的逆向思考： 他们的大部分估值已经反映了巨大的传统可插拔光学收入，而这些收入将不可避免地随时间被 cannibalize（ cannibalization蚕食），因此除非有人能利用杠杆，否则重新估值的空间有限。 许多新的纯CPO概念股会在H2 2026开始量产时从0到100极速增长（作为收入桥梁），然后进入H2 2027的规模化增长阶段（成为大规模增长驱动力）。 市场通常会在事件发生前8-12个月定价... 尽管在此期间市场可能出现波动，但我对自己的供应链研究在主题性方向上有高度信心。
英文原文
People wonder why I'm focusing on non-US markets recently. Why? CPO is my #1 thematic long. Markets don't know yet, the sudden paradigm shift in photonics... I was one of the only to frontrun the current supercycle in 2025 w/ $AAOI @ ~$30, $LITE ~$300s, and $AXTI at ~$13 on X.... With the actual receipts and thesis that others can't show. CPO goes from ~$0. To $91 Billion TAM opportunity. In the next 1 1/2 years from GS research. While overall optical market reaches $154B. Many players that had little exposure to the current photonics cycle at all: -> In Europe with high-end lasers design like $SIVE or $SOI with substrates. -> In Taiwan with Foci (3363), Nextronics (8147), Shunsin (6451) and others for optical components and foundries. -> In Japan with laser mass production, substrates, and chemicals. Are suddenly the new dominant players for CPO. As for US players, there's not much exposure. But the existing ones like $LITE, $COHR still get upside from CPO as that's their new growth vector. My contrarian thought process on current players: Is that most of their valuation is priced in huge legacy pluggable revenue that will inevitably face cannibalization over time, so re-rating potential is less unless someone uses leverage. A lot of these new purer play CPO names go from 0 to 100 extremely quickly one mass production starts H2 2026 for scale out (as a revenue bridge) into H2 2027 for scale up (massive growth driver). Markets usually price things in 8-12 months ahead of time too... I have high conviction thematically in my supply chain research despite any market volatility leading up until then.
-
解释设计/IP 型公司人手少是正常的
好问题！$SIVE 这种做 IP / design 的公司，员工数量没那么重要。 很多媒体在和 $COHR 这种需要成千上万人做组装的公司对比时，忽略了其中的差异。 $SIVE 把设计交给 Win Semi / $GFS 去生产，这也是我更喜欢这种模式的原因之一，因为在它们真正形成可观收入、再去做纵向整合之前，这样能大幅降低 capex 和稀释风险。 从美国视角看，我个人把这看成优点：保持轻资产和可扩展性。
英文原文
Hey great question! So $SIVE headcount doesn't matter as much when you're doing IP/design. Lot of media misunderstand nuances, when they compare it with $COHR that have tens of thousands of people... which are required for assembly. $SIVE ships their designs off to Win Semi / $GFS which handles all the production. Which is why I liked this model a lot more since it reduces a lot of capex and dilution risk until they make material revenue to vertically integrate. I personally see it as a plus, keeping things lean and scalable from an American perspective.
-
列出自己喜欢的一串 CPO 相关名字
和 CPO 相关、我喜欢的一些名字： - $SIVE - Foci (3363) - $TSEM - Browave (3163) - PCL (4977) - $AXTI - Msscorps (6830) - $IQE - Shunsin (6451) - Furukawa Electric (5801) - $MTSI - Nextronics (8417) - $LITE - $COHR - FitTech (6706) - $GFS - $ASX - LandMark (3081) - $SOI 披露一下：我大多都持有，但不是全部。
英文原文
Random CPO related names I like: - $SIVE - Foci (3363) - $TSEM - Browave (3163) - PCL (4977) - $AXTI - Msscorps (6830) - $IQE - Shunsin (6451) - Furukawa Electric (5801) - $MTSI - Nextronics (8417) - $LITE - $COHR - FitTech (6706) - $GFS - $ASX - LandMark (3081) - $SOI Disclosure: I own most, not all though.
-
分析Sivers作为CPO激光供应商的市场地位及垂直整合潜力。
我并没有说Sivers现在就应该被估值到100亿美元以上。 我说的是，如果Sivers在美股市场上市，我预期它的估值会在30亿美元左右。明年可能达到100亿美元以上。 因为他们很可能是$SIVE（$JBL、$MRVL、AMD、Ayar、els、Lightmatter、$POET等公司）的激光供应商，用于CPO或1.6T光收发器。 而且我高度确信他们正在与$AAPL合作开发用于消费类设备的硅光子(SiPH)技术。 根据高盛报告，CPO整体TAM（可寻址市场）在未来两年将从零增长到910亿美元。 Sivers向各大厂商供货，并从$LITE因受$NVDA产能分配限制以及2027年产量爬坡影响而停滞的溢出需求中获益。 然后他们只需要复制$LITE和$COHR的做法，通过收购封装IP或更多光引擎IP，向下游垂直整合完整的ELS（外接激光源）。 但首先他们得掌握激光这个瓶颈环节——而他们现在已经在做了。
英文原文
I didn’t say it should be valued at $10B+ today. I said I expected $SIVE to be around ~$3B if they were listed on US markets. And could be $10B+ next year Since they likely are the laser supplier to $JBL, $MRVL, $AMD, Ayar, onet(els), Lightmatter, $POET and many others for CPO or 1.6T optical transceivers. And high confidence work with $AAPL on SiPH for their consumer devices. CPO overall tam goes from 0 to $91B in the next two years from GS report. Sivers supplies to major players, and captures overflow from $LITE getting stalled out by capacity allocations from $NVDA and volume ramps over 2027. Then they just need to pull a $LITE $COHR then vertically integrate IP downstream by doing the full ELS by buying packaging IP or more optical engine IP. But that starts off by owning the laser chokepoint which they do now
-
AAOI被比作光学版Intel，借超大规模需求东风，2027年收入预测显示严重低估。
我之前在 $AAOI 市值 $6.49B 时就说过同样的话。 现在市值 $11.5B，故事还是一样的： 基本上这就是光学(Optics)版的 $INTC，他们正在将产能从激光晶圆制造扩展到美国本土组装。 他们生产的任何东西都可能被超大规模云厂商(Hyperscalers)收购。 如果看 2027 年中期预测的 $1.41B 季度收入增长（$471 x 3）与当前市值的对比，当前的财务数据其实不太重要。 以及高盛预测的 9 倍 TAM 增长曲线。
英文原文
I’ve said this before when $AAOI was $6.49B. Now it’s $11.5B and this is the same story: Basically this is the Optical version of $INTC, where they’re scaling capacity from laser fab to assembly Made in America. Anything they make is likely to be bought out by hyperscalers. Current financials don’t really mater if you look at $1.41B quarterly revenue ramp by mid 2027 projections ($471 x 3) vs current MC. And the overarching 9x TAM curve from GS projections.